LECAP Asset Management’s Gilead Sciences GILD Stock Holding History

LECAP Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$600K	Sell	4,746 -9	-0.2%	-$1.19K	0.26%	158
2026 Q1	$663K	Buy	+4,755	New	+$666K	0.25%	162
2025 Q3	–	Sell	-2,928	Closed	-$325K	–	327
2025 Q2	$325K	Sell	2,928 -6,323	-68%	-$673K	0.11%	251
2025 Q1	$1.04M	Sell	9,251 -769	-8%	-$79.3K	0.24%	171
2024 Q4	$926K	Sell	10,020 -3,030	-23%	-$273K	0.25%	157
2024 Q3	$1.09M	Buy	+13,050	New	+$996K	0.24%	156
2024 Q2	–	Sell	-16,325	Closed	-$1.2M	–	351
2024 Q1	$1.2M	Buy	+16,325	New	+$1.26M	0.25%	156

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LECAP Asset Management's GILD Position: Q2 2026 in Review

LECAP Asset Management reduced its Gilead Sciences (GILD) stake by 0.19% in Q2 2026, selling an estimated $1.19K and leaving 4,746 shares worth $600K. The position accounts for 0.26% of the portfolio, ranked #158.

LECAP Asset Management first reported a position in GILD in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.2M in Q1 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

LECAP Asset Management held 4,746 shares of Gilead Sciences worth $600K as of Q2 2026.
LECAP Asset Management sold 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
Gilead Sciences made up 0.26% of LECAP Asset Management's portfolio in Q2 2026, its #158 holding.
LECAP Asset Management first reported a position in Gilead Sciences in Q1 2024 and has held it in 7 quarters since.
LECAP Asset Management's Gilead Sciences position peaked at $1.2M in Q1 2024.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.